Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The portfolio's best-performing company during the month (+16.3% in USD). Released strong Q2...
— Dr Ian Mortimer, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Medtronic
Medtronic is cited as an example of a potential value trap that appears optically cheap at 15X EPS but fails to generate an ROIC above its cost of capital. Over time, its...
We also sold our position in Medtronic. We continue to...
More institutional theses from Guinness Global Innovators
The Fund's three semiconductor equipment holdings were the bottom performers over the quarter: KLA (-35.3% USD), Applied Materials (-29.2%), and Lam Research (-24.1%). This followed exceptionally...
Salesforce, the enterprise software giant, ended the quarter as the Fund's top performer. This follows a...
Microsoft was the Fund’s second best-performing stock over the third quarter, with the majority of the outperformance coming in July following an exceptionally strong earnings release. Microsoft has one...